Vista Pharmaceuticals Ltd.
Snapshot View

10.00 +0.01 ▲0.1%

09 February 2023, 02:21:00 PM
Volume: 1,356

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Market Cap 37.75 Cr.
Enterprise Value(EV) 50.15 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.18 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 58.62 Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share 9.37 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.10 Calculated using Price: 10.26
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.68 Cr. 36,793,907 Shares
FaceValue 2
Company Profile
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.10%
1 Week
+0.10%
1 Month
-17.29%
3 Month
+29.87%
6 Month
+48.15%
1 Year
-25.82%
2 Year
+5.49%
5 Year
-76.16%
10 Year
+90.84%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.27 13.94 7.15 8.97 10.19 3.15 -11.68 -6.43 -2.44
Return on Capital Employed (%) 5.38 14.16 9.57 8.92 12.42 6.28 -5.20 -5.10 -3.63
Return on Assets (%) 3.27 7.39 3.15 3.70 4.67 1.78 -7.11 -3.89 -1.59

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 9 10 11 17 32 36 30 33 35 34
Non Curr. Liab. 0 0 8 5 6 6 5 11 6 5
Curr. Liab. 5 12 7 19 15 11 16 9 11 12
Minority Int.
Equity & Liab. 14 23 26 41 53 53 51 53 52 52
Non Curr. Assets 12 11 10 16 25 29 30 37 37 36
Curr. Assets 2 12 16 26 28 23 21 15 15 16
Misc. Exp. not W/O
Total Assets 14 23 26 41 53 53 51 53 52 52

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 8 14 15 24 29 31 23 1 0 0
Other Income 0 0 0 0 0 3 4 0 0 0
Total Income 8 14 15 24 29 34 27 1 1 0
Total Expenditure -7 -11 -13 -21 -24 -30 -28 -3 -2 -1
PBIDT 1 3 3 3 6 4 -1 -2 -1 -1
Interest 0 -1 -1 -2 -2 -2 -2 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0 0 0 -1 0 0 2 2 3
Exceptional Items
PAT 0 1 1 1 2 1 -4 -2 -1 1
Adjusted EPS 0 1 0 0 1 0 -1 -1 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -4 -3 3 -5 3 1 -7 -1
Cash Fr. Inv. 0 0 0 0 -4 -11 -6 -2 0 0
Cash Fr. Finan. 0 4 3 6 11 1 0 7 1
Net Change 0 0 0 5 -4 -1 -1 0 0
Cash & Cash Eqvt 0 0 0 0 6 2 1 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 31.48 35.29 35.29 36.94 36.94 35.44 35.44 35.44 35.44
Public 68.52 64.71 64.71 63.06 63.06 64.56 64.56 64.56 64.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 07 Feb 2023
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.02.2023.
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve With reference to the subject cited the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Monday 13.02.2023 at 04.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70 1st Floor Plot No. 85 Shivbagh Ameerpet Hyderabad- 500016 Telangana inter-alia to discuss the following:1. To consider approve and take on record the un-audited Financial Results of the company for the quarter ended 31st December 2022.2. To consider and take note of Limited Review Report for the quarter ended 31st December 2022.3. Any other items with permission of chairman.
Fri, 20 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
With reference to the above-mentioned subject matter please find enclosed herewith certificate issued by Aarthi Consultants Private Limited Registrar and Share Transfer Agent confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations 2018 for the period from 01.10.2022 to 31.12.2022.
Sat, 31 Dec 2022
Closure of Trading Window
Notice is hereby given that in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 read with SEBI (Prohibition of insider Trading) Regulations 2015 as amended from time to time the Company has intimated to all its Directors Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01/01/2023 till 48 hours from the declaration of Financial Result for the quarter ended 31st December 2022.This closure of the Trading Window is occasioned by reason of declaration of financial results for the quarter ended 31st December 2022.All the insiders and their immediate relatives are hereby advised to take notice that in terms of trading restrictions placed under above regulations the Trading Window for the equity shares of the Company shall remain closed from 01/01/2023 till 48 hours after the declaration of the financial results for the quarter ended 31st December 2022.

Technical Scans View Details >>

Wed, 08 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Making Lower Lows for 3 days Making Lower Lows for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.30 -0.7%
Cipla Ltd. 83,886.47 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,495.00 +0.2%
Divi's Laboratories Ltd. 74,340.49 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,542.55 -0.9%
Zydus Lifesciences Ltd. 47,993.66 473.35 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-12 31.80 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.35 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-12 3.70 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.35 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.35 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.35 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.35 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.35 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.30 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,023.20 -1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,495.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,814.80 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,394.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,542.55 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.35 -0.1%

FAQ's On Vista Pharmaceuticals Ltd.

What is Vista Pharma share price?

Can I buy Vista Pharma shares now?

What is the Market Cap of Vista Pharma?

What are the key metrics to analyse Vista Pharma?

What is the 52 Week High and Low of Vista Pharma?

What is the trend of Vista Pharma share price?